MYOK Shares Outstanding History
Below is a table of the MYOK shares outstanding history going back to 10/29/2015:

Date MYOK Shares Outstanding

Also see: MYOK Market Cap History
MYOK Historical Shares Outstanding:
+15.86% CAGR
MYOK Historical Shares Outstanding: +15.86% CAGR

Mouse over chart for data details
10/29/2015 ...11/1/2020
MyoKardia is a clinical-stage biopharmaceutical company. Co.'s initial research has focused on genetic mutations in sarcomeric proteins of the heart muscle. Co.'s primary therapeutic candidate, mavacamten, is an orally administered allosteric modulator of cardiac myosin being developed for the treatment of hypertrophic cardiomyopathy (HCM). In addition to mavacamten, Co.'s programs include Danicamtiv, an orally-administered small molecule designed to increase cardiac contractility without impairing diastolic filling in patients with systolic heart failure; and MYK-224, a small molecule program for the treatment of HCM targeting hypercontractility and impaired relaxation. We show 23 historical shares outstanding datapoints in our coverage of MYOK's shares outstanding history.

Understanding the changing numbers of MYOK shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like MYOK versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching MYOK by allowing them to research MYOK shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree MYOK Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
MyoKardia (MYOK) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

NAOV Shares Outstanding History
NARI Shares Outstanding History
NATR Shares Outstanding History
NBIX Shares Outstanding History
NBSE Shares Outstanding History
NDRA Shares Outstanding History
NEO Shares Outstanding History
NEOG Shares Outstanding History
NEOS Shares Outstanding History
NERV Shares Outstanding History
More Healthcare companies »


MYOK Shares Outstanding History | | Copyright © 2017 - 2022, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.